Elsevier

Dermatologic Clinics

Volume 26, Issue 2, April 2008, Pages 191-202
Dermatologic Clinics

Syphilis: The International Challenge of the Great Imitator

https://doi.org/10.1016/j.det.2007.12.001Get rights and content

Syphilis is a systemic disease caused by the spirochete Treponema pallidum. The name of this ancient but pervasive infection is proverbial to health care providers. The worldwide recognition of this term, however, argues with the intricacy of the disease in addition to the diagnostic and therapeutic challenges that persistently affect the global control of syphilis up to the present. This article focuses on the varied presentations of the infection, earning the title the “great imitator.” The article also tackles other significant concerns regarding this malady.

Section snippets

The many faces of syphilis

During the secondary stage, there is rapid reproduction and spread of the spirochetes consequential to intensive clinical manifestations. Patients may experience a range of constitutional symptoms, such as malaise, appetite loss, fever, headache, stiff neck, lacrimation, myalgias, arthralgias, nasal discharge, and depression. There is multiorgan involvement of the skin, oral cavity, genitalia, central nervous system, eyes, and visceral organs. Among these symptoms, skin eruptions proved to be

Diagnostic and serologic tests

Darkfield examination and a direct fluorescent antibody test of lesion exudates or tissue are the definitive methods for diagnosing early syphilis. A presumptive diagnosis is made with the use of two types of serologic tests: nontreponemal tests (eg, Venereal Disease Research Laboratory [VDRL] and rapid plasma reagin [RPR]), and treponemal tests (eg, fluorescent treponemal antibody absorbed and T. pallidum particle agglutination). The use of only one type of serologic test is insufficient for

Therapeutic options

Syphilis is a disease of considerable health magnitude and has devastating untoward health effects if left untreated. It is avoidable. It is treatable with the use of effective antibiotics.

The design challenge for syphilis elimination is not only to efficiently pursue the riddance of T. pallidum. There should be an intense call for a clinical network of physicians and other sexual health service providers to be at the center of syphilis and sexually transmitted infection (STI) surveillance to

Follow-up guidelines

The Centers for Disease Control has set up guidelines regarding follow-up of patients in different stages of syphilis (Table 2).

Management of sex partners

Persons exposed sexually to a patient who has syphilis in any stage should be evaluated clinically and serologically. They should be treated with a regimen based on the following recommendations [10]:

  • Persons who were exposed within 90 days preceding the diagnosis of primary, secondary, or early latent syphilis in a sexual partner who might be infected even if seronegative; therefore, such persons should be treated presumptively.

  • Persons who were exposed more than 90 days before the diagnosis of

Summary

Syphilis has been a source of social stigma, morbidity, and mortality for centuries. Although the introduction of penicillin in the 1940's contributed much to the decrease in epidemiology, statistics show that it is still a menace to our society.

Syphilis is a rare occurrence in children; therefore, a diagnosis of syphilis in a child warrants an investigation of sexual abuse. Emphasis that this disease is as damaging to the soul as it is to the body, especially in the case of a minor, is vital.

Acknowledgment

The authors thank Dr. Gertrude P. Chan, Section Head of Dermatology at the Research Institute for Tropical Medicine–Department of Health, Philippines and the resident physicians for the assistance with photograph collection.

References (35)

  • A. Olson et al.

    A 50-year-old man with skin lesions and multiple pulmonary nodules

    Chest

    (2004)
  • K. Wellings et al.

    Sexual behaviour in Britain; early heterosexual experience

    Lancet

    (2001)
  • S. Gould

    Syphilis and the shepherd of Atlantis – renaissance poem about syphilis attempts to explain its origin; genetic map revealed in 1998

    Nat Hist

    (2000)
  • I.M. Freedberg et al.
    (2003)
  • K. Carlson-Sweet et al.

    Multiple annular plaques on the face of a middle-aged woman

    Arch Dermatol

    (2000)
  • D. Harden et al.

    Papular and nodular lesions of the scalp, face, and neck

    Arch Dermatol

    (1997)
  • P. French

    Syphilis

    BMJ

    (2007)
  • J. Junkins-Hopkins

    Multiple painful oral ulcerations

    Arch Dermatol

    (1995)
  • R. Casey et al.

    Anterior nodular scleritis secondary to syphilis

    Archives of Ophthalmology

    (1996)
  • D.L. Coleman et al.

    Secondary syphilis with pulmonary involvement

    West J Med

    (1983)
  • K. Workowski et al.

    Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006

    MMWR Recomm Rep

    (2006)
  • M. St. Louis et al.

    Elimination of syphilis in the United States

    Science

    (1998)
  • D. Campos-Outcalt

    Sexually transmitted disease: easier screening tests, single-dose therapies

    J Fam Pract

    (2003)
  • M. Genç et al.

    Syphilis in pregnancy

    Sex Transm Infect

    (2000)
  • K.A. Workowski et al.

    U.S. Centers for Disease Control and Prevention guidelines for the treatment of sexually transmitted diseases: an opportunity to unify clinical and public health practice

    Ann Intern Med

    (2002)
  • M.S. Verdon et al.

    Pilot study of azithromycin for treatment of primary and secondary syphilis

    Clin Infect Dis

    (1994)
  • E.W. Hook et al.

    Azithromycin compared with penicillin G benzathine for treatment of incubating syphilis

    Ann Intern Med

    (1999)
  • Cited by (38)

    • Histologic features of secondary syphilis: A multicenter retrospective review

      2015, Journal of the American Academy of Dermatology
    • Oral syphilis: Report of three cases and characterization of the inflammatory cells

      2015, Annals of Diagnostic Pathology
      Citation Excerpt :

      In the present study, the efficacy of this drug was demonstrated by the administration of a weekly dose of 2.4 million units (IM) and the observation of complete remission of the lesions after the first dose. However, the patients should be followed up by serologic testing at 6 and 12 months posttreatment [11]. Syphilis has important implications for clinicians because manifestations can occur in the mouth and perioral region and primary and secondary lesions are highly contagious.

    • Clavi syphilitici-an unusual presentation of syphilis

      2014, Journal of the American Academy of Dermatology
    View all citing articles on Scopus
    View full text